| William M Tierney, MD | |
|
825 Ne 10th St, Oupb 2300, Oklahoma City, OK 73104-5417 | |
| (405) 271-8478 | |
| Not Available |
| Full Name | William M Tierney |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 34 Years |
| Location | 825 Ne 10th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255300513 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 20307 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ou Health Partners Inc | 5991105876 | 779 |
News Archive
In a bid to reduce the smoking rates in Australia's indigenous population the Federal Government is launching the first anti-smoking campaign this Monday (today) aimed specifically at indigenous Australians. Figures have shown that nearly 50% Aboriginal and Torres Strait Islander people smoke, and one in five die from smoking-related diseases. According to Government spokesmen the new campaign is part of its plan to halve the number of indigenous smokers by 2018. The radio, television and print campaign will cost $4 million and is part of the Government's wider aim to significantly reduce the number of Australians who smoke.
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
In the latest sign of Pittsburgh's growing importance as a center of health care technology innovation, the Pittsburgh Health Data Alliance announced today that it is working closely with Amazon Web Services, an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.
› Verified 9 days ago
| Entity Name | Board Of Regents Of The University Of Oklahoma - Ou Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801869250 PECOS PAC ID: 2860304334 Enrollment ID: O20031103000607 |
News Archive
In a bid to reduce the smoking rates in Australia's indigenous population the Federal Government is launching the first anti-smoking campaign this Monday (today) aimed specifically at indigenous Australians. Figures have shown that nearly 50% Aboriginal and Torres Strait Islander people smoke, and one in five die from smoking-related diseases. According to Government spokesmen the new campaign is part of its plan to halve the number of indigenous smokers by 2018. The radio, television and print campaign will cost $4 million and is part of the Government's wider aim to significantly reduce the number of Australians who smoke.
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
In the latest sign of Pittsburgh's growing importance as a center of health care technology innovation, the Pittsburgh Health Data Alliance announced today that it is working closely with Amazon Web Services, an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.
› Verified 9 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
In a bid to reduce the smoking rates in Australia's indigenous population the Federal Government is launching the first anti-smoking campaign this Monday (today) aimed specifically at indigenous Australians. Figures have shown that nearly 50% Aboriginal and Torres Strait Islander people smoke, and one in five die from smoking-related diseases. According to Government spokesmen the new campaign is part of its plan to halve the number of indigenous smokers by 2018. The radio, television and print campaign will cost $4 million and is part of the Government's wider aim to significantly reduce the number of Australians who smoke.
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
In the latest sign of Pittsburgh's growing importance as a center of health care technology innovation, the Pittsburgh Health Data Alliance announced today that it is working closely with Amazon Web Services, an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William M Tierney, MD 1122 Ne 13th St, Ori 236, Oklahoma City, OK 73117-1039 Ph: (405) 271-1515 | William M Tierney, MD 825 Ne 10th St, Oupb 2300, Oklahoma City, OK 73104-5417 Ph: (405) 271-8478 |
News Archive
In a bid to reduce the smoking rates in Australia's indigenous population the Federal Government is launching the first anti-smoking campaign this Monday (today) aimed specifically at indigenous Australians. Figures have shown that nearly 50% Aboriginal and Torres Strait Islander people smoke, and one in five die from smoking-related diseases. According to Government spokesmen the new campaign is part of its plan to halve the number of indigenous smokers by 2018. The radio, television and print campaign will cost $4 million and is part of the Government's wider aim to significantly reduce the number of Australians who smoke.
A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
In the latest sign of Pittsburgh's growing importance as a center of health care technology innovation, the Pittsburgh Health Data Alliance announced today that it is working closely with Amazon Web Services, an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.
› Verified 9 days ago
Evelyn Lorents, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |